Perth-based Argenica Therapeutics has partnered with an Oxford University AI spinout to evaluate the effectiveness of its flagship ARG-007 stroke drug, finding previously hidden impacts.
This week's appointments include Robert Mencel, Neema Premji, Louise Pratt, Peter Chellew, Enzo Evangelista, Arron Minchin, Jamie Stewart, Vanessa Torres, Gerard Danckert, Michelle Carey, Rebecca Hamilton, Dennis O'Reilly, and others.
Stan Perron Charitable Foundation's commitment to Perth Children's Hospital's rare and undiagnosed disease centre is one of the largest philanthropic donations in Western Australia.
This week's appointments include Professor Merrilee Needham, Marcus Canning, Ben Morton, Ross Carroll, Lawrie Tremaine, Jason Fletcher, and Vik Bansal.
Neurology professor Merrilee Needham has been named the Perron Institute's new medical director, taking over from Professor David Blacker after he spent more than a decade in the role.
Three Perth pharmaceutical companies will take a share of a $12 million funding injection by the federal government to develop Australian-made heart disease and diabetes treatments.
Researchers from UWA and the Perron Institute have discovered a new set of cells which can protect blood vessel structure in the central nervous system, know as the blood-brain barrier.
Perth biotech company Argenica Therapeutics' drug, which is designed to reduce brain tissue death following a stroke, will be administrated at two local hospitals in a nationwide trial.
Perron Institute postdoctoral researcher Oliver Li has won a grant valued at more than $500,000 to lead a research project developing effective treatment for motor neurone disease.
Local scientists have won significant funding from the US military because its veterans are more likely to suffer from a debilitating motor neurone disease they are researching.
Our weekly appointments wrap includes Paul Larsen, Stephen Daly, Jodie Perram, Leigh Dyson, Scott Lowe, Bianca Sandri, Felicity Gooding, Shelley Cable and Michael Keenan.
Our weekly appointments wrap includes Chrissie Maus, Vlad Mrdak, Fiona Seaward, John Ivulich, Patrick Creaghan, John Ivulich, John Finlay-Jones, Rebekah Puls, Cameron Belyea, Nick Cooper, Doug Warden, Marie Van Blommestein, Reagan Manns, Rhys Edwards, Michael Schaper and Lanie Chopping.
A nine-year old licencing deal signed on behalf of WA medical researchers is continuing to deliver returns, with US company Sarepta Therapeutics paying $11.5 million in royalties last year.
A Perth startup led by three tech veterans is planning to manufacture and export a new high-speed COVID testing machine after getting backing from the state government.
Our weekly appointments wrap includes Jessica Machin, Clint Bracknell, Mimi Packer, James Williams, Peter Cook, Marianne Dravnieks, Andrew Kennedy, Fiona Murfitt and Giulia Savior.
Elizabeth Perron has been given the daunting task of continuing her late father's philanthropic legacy. She spoke to Business News about how she is tackling this task.
Home to some of Australia's most heralded and important research foundations, WA's relative isolation has done little to dampen the medical research sector's inspiration for innovation. Here are some of the leading lights dedicated to making the state, and the world, a healthier place to live.
Perron Group has announced key board appointments after the passing of its founder Stan Perron and disclosed the “greater majority” of its $4 billion in net assets will be donated to charity.
Stan Perron's long and influential role in WA has continued with his recent commitment to donate $10 million to the Perron Institute for Neurological and Translational Science.
Stan and Jean Perron have announced they will be donating $10 million across 10 years to the Perron Institute for Neurological and Translational Science, adding to a multitude of reasons Mr Perron was awarded State Shaper by The 500 Club today.
Technology that recently arrived in Perth from New Zealand could improve rehabilitation outcomes for multiple sclerosis and stroke patients, offering the potential to speed-up recovery while reducing the need to travel for treatment.
